Be A Freedom Fighter · Bill Library

HR 10770 — 340B Rebate Model Delay Act

Freedom score: 0 (scale −10 to +10)

Sponsor: Rep. Bresnahan, Robert P. [R-PA-8] · Latest action: Referred to the House Committee on Energy and Commerce. (2026-10-09)

Full text on GovInfo (introduced version) · Congress.gov · ← Bill Library index

Findings — 5 highlighted provisions

Each item below is one provision documented in the findings file. The same provision is highlighted in the full text underneath, with its section citation and criterion. Everything else on this page is plain, unreviewed bill text.

  1. Sec. 1 — supplies the short title See in text ↓
  2. Sec. 2(a) · Economic Freedom — new Public Health Service Act §340B(a)(11) temporarily prohibits the HHS Secretary from entering manufacturer agreements under §340B(a)(1) that require covered entities other than those in §340B(a)(4)(E) to pay more at the point of purchase than the already applicable 340B ceiling price. This locks in upfront price protection for the covered entities during the stated period; it does not repeal the existing discounted-price program or simply ban every rebate arrangement outside its terms See in text ↓
  3. Sec. 2(a) · Economic Freedom — contains the literal time formulation "For the period beginning on January 1, 2027, the date of enactment of this paragraph, and ending on December 31, 2028". The juxtaposition of January 1, 2027 and "the date of enactment" is a drafting ambiguity, not an express later-of formula. The specified end is December 31, 2028; implementation timing is uncertain if enacted on another date See in text ↓
  4. Sec. 2(b) — independently says that, during the similarly specified period, HHS may not implement the specifically identified August 3, 2026 340B Rebate Model Pilot Program or any substantially similar program. The pilot notice had proposed manufacturer plans beginning January 1, 2027. The bill therefore delays an agency change in the manner of delivering the existing 340B discounts, rather than newly establishing free-market drug prices See in text ↓
  5. Sec. 2(a)–(b) · Economic Freedom — is time limited and restrains an agency and the manufacturer-agreement format; it does not change federal criminal law or enact a general pharmacy rebate ban See in text ↓

Full text (introduced version)

3 of 4 text blocks highlighted. Source: GovInfo, fetched cached.

[Congressional Bills 119th Congress] [From the U.S. Government Publishing Office] [H.R. 10770 Introduced in House (IH)] <DOC> 119th CONGRESS 2d Session H. R. 10770 To amend title III of the Public Health Service Act to temporarily limit the use of rebates under the 340B Program. _______________________________________________________________________ IN THE HOUSE OF REPRESENTATIVES October 9, 2026 Mr. Bresnahan (for himself, Mrs. Dingell, Mr. Mann, and Ms. Lois Frankel of Florida) introduced the following bill; which was referred to the Committee on Energy and Commerce _______________________________________________________________________ A BILL To amend title III of the Public Health Service Act to temporarily limit the use of rebates under the 340B Program. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

Sec. 1 — supplies the short title

This Act may be cited as the ``340B Rebate Model Delay Act''.

SEC. 2. LIMITING USE OF REBATES UNDER THE 340B PROGRAM.

Sec. 2(a) · Economic Freedom — new Public Health Service Act §340B(a)(11) temporarily prohibits the HHS Secretary from entering manufacturer agreements under §340B(a)(1) that require covered entities other than those in §340B(a)(4)(E) to pay more at the point of purchase than the already applicable 340B ceiling price. This locks in upfront price protection for the covered entities during the stated period; it does not repeal the existing discounted-price program or simply ban every rebate arrangement outside its terms

Sec. 2(a) · Economic Freedom — contains the literal time formulation "For the period beginning on January 1, 2027, the date of enactment of this paragraph, and ending on December 31, 2028". The juxtaposition of January 1, 2027 and "the date of enactment" is a drafting ambiguity, not an express later-of formula. The specified end is December 31, 2028; implementation timing is uncertain if enacted on another date

Sec. 2(a)–(b) · Economic Freedom — is time limited and restrains an agency and the manufacturer-agreement format; it does not change federal criminal law or enact a general pharmacy rebate ban

(a) In General.--Section 340B(a) of the Public Health Service Act (42 U.S.C. 256b(a)) is amended by adding at the end the following new paragraph:
``(11) Temporary limit on use of rebates.--For the period beginning on January 1, 2027, the date of enactment of this paragraph, and ending on December 31, 2028, the Secretary may not enter into an agreement with a manufacturer of covered outpatient drugs under paragraph (1) under which the amount required to be paid to the manufacturer for covered outpatient drugs by a covered entity (other than a covered entity described in paragraph (4)(E)) exceeds, at the point of purchase of such drug, the applicable ceiling price for such drug (as described in paragraph (1)).''.

Sec. 2(b) — independently says that, during the similarly specified period, HHS may not implement the specifically identified August 3, 2026 340B Rebate Model Pilot Program or any substantially similar program. The pilot notice had proposed manufacturer plans beginning January 1, 2027. The bill therefore delays an agency change in the manner of delivering the existing 340B discounts, rather than newly establishing free-market drug prices

Sec. 2(a)–(b) · Economic Freedom — is time limited and restrains an agency and the manufacturer-agreement format; it does not change federal criminal law or enact a general pharmacy rebate ban

(b) Delaying Implementation of 340B Rebate Model Pilot Program.-- For the period beginning on January 1, 2027, the date of enactment of this section, and ending on December 31, 2028, the Secretary of Health and Human Services may not implement the 340B Rebate Model Pilot Program described in the notice titled ``Notice Regarding 340B Rebate Model Pilot Program'' (91 Fed. Reg. 48883 (August 3, 2026)), or any substantially similar program. <all>

Findings source: bill-scores-v2-batch42-findings-2026-11-15.md. Highlights come only from that file; no finding, score, or provision was invented for this page.

What you can do

Contact your U.S. Representative and Senators about this bill.

Find your Representative Contact your Senators

Spot an error on this page? Report it.